The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADMA BIOLOGICS INC | COM | 000899104 | 22,762 | 5,114,986 | SH | SOLE | 5,114,986 | 0 | 0 | ||
ALIGN TECHNOLOGY INC | COM | 016255101 | 54,095 | 299,000 | SH | SOLE | 299,000 | 0 | 0 | ||
AMARIN CORP PLC | SPONS ADR NEW | 023111206 | 96,876 | 6,390,259 | SH | SOLE | 6,390,259 | 0 | 0 | ||
ANI PHARMACEUTICALS INC | COM | 00182C103 | 10,418 | 142,943 | SH | SOLE | 142,943 | 0 | 0 | ||
ARQULE INC | COM | 04269E107 | 28,761 | 4,011,342 | SH | SOLE | 4,011,342 | 0 | 0 | ||
AURINIA PHARMACEUTICALS INC | COM | 05156V102 | 13,677 | 2,561,269 | SH | SOLE | 2,561,269 | 0 | 0 | ||
CAREDX INC | COM | 14167L103 | 16,418 | 726,128 | SH | SOLE | 726,128 | 0 | 0 | ||
CATALYST PHARMACEUTICALS INC | COM | 14888U101 | 94,920 | 17,875,655 | SH | SOLE | 17,875,655 | 0 | 0 | ||
CHEMOCENTRYX INC | COM | 16383L106 | 11,300 | 1,666,667 | SH | SOLE | 1,666,667 | 0 | 0 | ||
EPIZYME INC | COM | 29428V104 | 41,003 | 3,975,054 | SH | SOLE | 3,975,054 | 0 | 0 | ||
GLOBUS MED INC | CL A | 379577208 | 67,130 | 1,313,177 | SH | SOLE | 1,313,177 | 0 | 0 | ||
HOMOLOGY MEDICINES INC | COM | 438083107 | 734 | 40,557 | SH | SOLE | 40,557 | 0 | 0 | ||
IMMUNOMEDICS INC | COM | 452907108 | 597 | 45,000 | SH | SOLE | 45,000 | 0 | 0 | ||
INSULET CORP | COM | 45784P101 | 25,696 | 155,800 | SH | SOLE | 155,800 | 0 | 0 | ||
INTRA CELLULAR THERAPIES INC | COM | 46116X101 | 149 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 30,564 | 1,679,327 | SH | SOLE | 1,679,327 | 0 | 0 | ||
KADMON HLDGS INC | COM | 48283N106 | 26,948 | 10,693,574 | SH | SOLE | 10,693,574 | 0 | 0 | ||
KARYOPHARM THERAPEUTICS INC | COM | 48576U106 | 56,156 | 5,837,434 | SH | SOLE | 5,837,434 | 0 | 0 | ||
KRYSTAL BIOTECH INC | COM | 501147102 | 7,782 | 224,090 | SH | SOLE | 224,090 | 0 | 0 | ||
MUSTANG BIO INC | COM | 62818Q104 | 10,302 | 3,160,000 | SH | SOLE | 3,160,000 | 0 | 0 | ||
OMEROS CORP | COM | 682143102 | 46,232 | 2,831,109 | SH | SOLE | 2,831,109 | 0 | 0 | ||
OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 35,663 | 2,144,524 | SH | SOLE | 2,144,524 | 0 | 0 | ||
RETROPHIN INC | COM | 761299106 | 26,824 | 2,314,421 | SH | SOLE | 2,314,421 | 0 | 0 | ||
SAREPTA THERAPEUTICS INC | COM | 803607100 | 904 | 12,000 | SH | SOLE | 12,000 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 4,155 | 1,568,002 | SH | SOLE | 1,568,002 | 0 | 0 | ||
STAAR SURGICAL CO | COM PAR $0.01 | 852312305 | 31,652 | 1,227,771 | SH | SOLE | 1,227,771 | 0 | 0 | ||
TANDEM DIABETES CARE INC | COM NEW | 875372203 | 60,293 | 1,022,257 | SH | SOLE | 1,022,257 | 0 | 0 | ||
UNIQURE NV | SHS | N90064101 | 56,214 | 1,428,202 | SH | SOLE | 1,428,202 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 77,164 | 967,569 | SH | SOLE | 967,569 | 0 | 0 | ||
VERICEL CORP | COM | 92346J108 | 55,178 | 3,644,492 | SH | SOLE | 3,644,492 | 0 | 0 |